Abstract
Infective endocarditis (IE) with non-HACEK Gram-negative (GN) organisms is rare, but associated with poor outcomes. The purpose of this study was to quantify the microbiology, treatment strategies, and frequency of poor outcomes in patients with non-HACEK GN IE. Retrospective cohort of adults with definite non-HACEK GN IE from 1/11-1/19. The primary endpoint was poor patient outcome, defined as a composite of all-cause death or infection-related readmission within 90-days of index infection. 43 patients were included: 51% patients were men, and the median (IQR) age was 40 (31-50) years. Forty patients reported injection drug use. The most common organisms were Pseudomonas aeruginosa (68%) and Serratia marcescens (9%). Seventy-six percent of patients received definitive combination therapy; the most common antibiotics used in combination with a β-lactam were aminoglycosides (50%) and fluoroquinolones (34%). Three patients discontinued combination therapy due to toxicity. Twelve-month, all-cause mortality and readmission was 30% and 54%, respectively. In multivariable logistic regression, variables independently associated with composite poor outcome were receipt of fluoroquinolone-based IE combination therapy and septic shock. L...Continue Reading
References
Nov 1, 1979·Progress in Cardiovascular Diseases·B E Reisberg
Jan 1, 1976·Annals of Internal Medicine·J Mills, D Drew
Jul 1, 1990·Reviews of Infectious Diseases·S V KomshianM P Reyes
May 1, 1986·Reviews of Infectious Diseases·D P LevineM J Zervos
Jan 1, 1973·Annals of Internal Medicine·K B Menda, S L Gorbach
Dec 4, 2004·Journal of Bacteriology·Iris KerenKim Lewis
Dec 19, 2007·Annals of Internal Medicine·Susan MorpethUNKNOWN International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators
Mar 11, 2009·Archives of Internal Medicine·David R MurdochUNKNOWN International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators
Sep 12, 2009·Medicine·Milagros P ReyesDouglas J Biedenbach
Jul 29, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A-P MagiorakosD L Monnet
Jan 30, 2013·BMC Infectious Diseases·Carlos J SanchezClinton K Murray
Jun 16, 2015·PloS One·Hansel TookesSusanne Doblecki-Lewis
Aug 12, 2015·Infectious Diseases·Paul LoubetVeronique Joly
Sep 17, 2015·Circulation·Larry M BaddourUNKNOWN American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular
Oct 27, 2015·Pharmacotherapy·Keith S Kaye, Jason M Pogue
Jan 31, 2016·Interactive Cardiovascular and Thoracic Surgery·Oda Bratland ØsterdalRune Haaverstad
Jun 28, 2016·Infectious Diseases in Clinical Practice : IDCP·Varun K Phadke, Jesse T Jacob
Jan 31, 2018·Antimicrobial Agents and Chemotherapy·Marco FalconeMarco Rizzi
Oct 26, 2018·BMC Infectious Diseases·Megan E GrayRebecca A Dillingham
Citations
Sep 3, 2020·Journal of Chemotherapy·Petros IoannouDiamantis P Kofteridis
Sep 10, 2020·Expert Review of Anti-infective Therapy·David Luque PazPierre Tattevin
Feb 14, 2021·Medicina·Emilia Elena BabeșVlad Victor Babeș
Feb 6, 2021·Tropical Medicine and Infectious Disease·Petros IoannouDiamantis P Kofteridis
Feb 20, 2021·Journal of Chemotherapy·Petros IoannouDiamantis P Kofteridis
Jun 29, 2021·Virulence·Charles D MorinGee W Lau
Aug 10, 2021·Journal of Chemotherapy·Petros IoannouDiamantis P Kofteridis
Aug 11, 2021·Diagnostic Microbiology and Infectious Disease·Ashley LorenzLynn Wardlow
Sep 11, 2021·European Journal of Internal Medicine·Ricardo Serrano, Jordi Rello
Oct 21, 2021·Current Opinion in Infectious Diseases·Emilio BouzaAlmudena Burillo